IMUX
Immunic Inc
NASDAQ: IMUX · HEALTHCARE · BIOTECHNOLOGY
$7.98
+4.86% today
Updated 2026-10-28
Market cap
$98.51M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-3.69
Dividend yield
—
52W range
$5 – $17
Volume
0.4M
WallStSmart proprietary scores
29
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C6.0
Quality
B3.0
Profitability
D5.0
Valuation
C+1/9
Piotroski F-Score
Weak
-49.1
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →270 stocks currently score above 75
Price targets
Analyst target
$43.09
+439.97%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
0 Strong Buy12 Buy0 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ Debt/equity 0.00x — low leverage
Risks
- Piotroski 1/9 — weak financial health
- Altman Z -49.14 — distress zone
- Thin margins at 0.00%
- Negative free cash flow $-31.25M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-120.41M | $-93.61M | $-100.51M | $-97.17M | $-34.10M |
| EPS | — | — | — | — | $-3.69 |
| Free cash flow | $-65.26M | $-71.16M | $-85.03M | $-85.97M | $-31.25M |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
Immunic Inc trades at $7.98. Our Smart Value Score of 29/100 indicates the stock is weak. The company scores 1/9 on the Piotroski F-Score. With an Altman Z-Score of -49.14, it sits in the distress.
Frequently asked questions
What is Immunic Inc's stock price?
Immunic Inc (IMUX) trades at $7.98.
Is Immunic Inc overvalued?
Immunic Inc carries a Smart Value Score of 29/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.
What is the price target of Immunic Inc (IMUX)?
The 12-month analyst consensus target is $43.09, about 440.0% above the current $7.98. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
Altman Z-Score?
Immunic Inc's Altman Z-Score is -49.14, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE-68.96%
Beta1.45
50D MA$11.30
200D MA$11.47
Shares out0.01B
Float0.01B
Short ratio—
Avg volume0.4M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—